Bristol-Myers Squibb Correlations

The correlation of Bristol-Myers Squibb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bristol-Myers Squibb moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bristol Myers Squibb moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
  
The ability to find closely correlated positions to Bristol-Myers Squibb could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol-Myers Squibb when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol-Myers Squibb - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol Myers Squibb to buy it.

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RHHBYRHHVF
ALPMYALPMF
ALPMYNVSEF
BAYZFNVSEF
ALPMFNVSEF
RHHBYNVSEF
  
High negative correlations   
CHGCYOTSKF
OTSKFDSKYF
OTSKFALPMY
AZNCFALPMY
OTSKFALPMF
AZNCFNVSEF

Risk-Adjusted Indicators

There is a big difference between Bristol-Myers Pink Sheet performing well and Bristol-Myers Squibb Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bristol-Myers Squibb's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NVSEF  1.11 (0.17) 0.00 (1.34) 0.00 
 2.48 
 7.44 
BAYZF  1.55 (0.38) 0.00 (0.26) 0.00 
 2.85 
 11.75 
ALPMF  1.72 (0.37) 0.00 (0.70) 0.00 
 4.78 
 14.52 
RHHVF  1.20 (0.17) 0.00 (0.24) 0.00 
 2.29 
 6.09 
ALPMY  0.92 (0.36) 0.00 (0.42) 0.00 
 1.58 
 9.73 
DSKYF  2.28  0.14  0.02  1.19  2.76 
 4.58 
 10.73 
AZNCF  1.58  0.11  0.02  0.58  1.88 
 3.40 
 10.78 
OTSKF  0.37  0.06  0.00  7.50  0.00 
 0.00 
 9.35 
CHGCY  1.60 (0.23) 0.00 (0.21) 0.00 
 2.83 
 9.53 
RHHBY  1.03 (0.16) 0.00 (0.30) 0.00 
 1.64 
 6.23 

Bristol-Myers Squibb Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bristol-Myers Squibb pink sheet to make a market-neutral strategy. Peer analysis of Bristol-Myers Squibb could also be used in its relative valuation, which is a method of valuing Bristol-Myers Squibb by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Bristol-Myers Squibb Corporate Directors

Bristol-Myers Squibb corporate directors refer to members of a Bristol-Myers Squibb board of directors. The board of directors generally takes responsibility for the Bristol-Myers Squibb's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bristol-Myers Squibb's board members must vote for the resolution. The Bristol-Myers Squibb board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Togo WestIndependent DirectorProfile
Karen VousdenDirectorProfile
Alan LacyIndependent DirectorProfile
Robert BertoliniIndependent DirectorProfile

Still Interested in Bristol Myers Squibb?

Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in Bristol-Myers Pink Sheet

If you are still planning to invest in Bristol Myers Squibb check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bristol-Myers Squibb's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies